To include your compound in the COVID-19 Resource Center, submit it here.

Ophthalmic play ViewPoint raises $35M series B

ViewPoint Therapeutics Inc. (San Francisco, Calif.) raised $35 million in a series

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE